CaRD 2012
Data on cancer research funding by NCRI partners has now been collected for 11 consecutive years from 2002 to 2012. In this time the amount spent on cancer research has increased from £257m in 2002 to £507m in 2012.
Around 60% of the research funded is relevant to all types of cancer. The diagram below shows how the 40% for site-specific research is divided amongst the commonest cancers.
For some cancer sites funding has improved over and above the growth in the portfolio as a whole, eg cancers of the lung, oesophagus and pancreas.
The full cancer research funding data package for all years 2002-2012 is available as a spreadsheet. View CaRD 2002-2012 data package.
For all questions on the data please contact the CaRD Research Analyst.
Note: If you wish to reproduce these data in any publication please contact the CaRD Research Analyst.
